In 2019, the FDA issued a warning about serious breathing problems with seizure and nerve pain medicines gabapentin and pregabalin when used with CNS depressants or in patients with lung problems. Gabapentin and pregabalin are FDA-approved for a variety of conditions, including seizures, nerve pain, and restless legs syndrome. Even with this warning, a recent study found that use of …